COMMUNIQUÉS West-GlobeNewswire

Woebot Secures $8 Million in Funding to Increase Access to Mental Health Care Worldwide
01/03/2018
SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Today, Woebot Labs, Inc. announced an $8 million Series A funding round from leading venture capital firm New Enterprise Associates (NEA) with participation from Andrew [...]
Otonomy to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Corporate Update
01/03/2018
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will report financial [...]
BioCorRx Schedules Business Update Conference Call
01/03/2018
ANAHEIM, CA, March 01, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced it will [...]
Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Highlights
01/03/2018
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today reported financial [...]
CareDx to Refinance Debt with Perceptive Advisors
01/03/2018
Balance Sheet to be Simplified with Single Term Loan BRISBANE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and [...]
Myriad Genetics Demonstrates Strong Commitment to Preventing Hereditary Colon Cancer as Part of National Colorectal Cancer Awareness Month
01/03/2018
SALT LAKE CITY, March 01, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary [...]
ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting
01/03/2018
Oral administration of OBE022 shows favorable safety and results in predictable exposure Non-clinical results of OBE022 for PTL demonstrating fetal safety Geneva, Switzerland and Boston, MA - 01 March 2018 - ObsEva SA ( [...]
Shire plc : Director/PDMR Shareholding
01/03/2018
Director/PDMR Shareholding March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet™ Needle-Free Delivery System
01/03/2018
EWING, N.J., March 01, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (“Antares”) today announced that it has received $2.75 million from Ferring Pharmaceuticals (“Ferring”) in connection with the [...]
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
01/03/2018
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Sunesis Pharmaceuticals to Host Conference Call on March 8th to Discuss Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights
01/03/2018
SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that it will host a conference call on Thursday, March 8th, 2018 at 1:30 p.m. Pacific Time to [...]
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8
01/03/2018
REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after [...]
Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial Evaluating IMO-2125 in Combination with Ipilimumab for the Treatment of Anti-PD-1 Refractory Melanoma (ILLUMINATE 301)
01/03/2018
EXTON, Pa. and CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients [...]
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2017 Results
01/03/2018
NASHVILLE, Tenn., March 01, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter [...]
Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program
01/03/2018
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive ") (TSX-V: RVV ) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, and [...]
Chimerix Announces Fourth Quarter and Full Year 2017 Financial Results
01/03/2018
- AdVance Data to be Presented at EBMT Annual Meeting - - Oral and IV BCV Programs Remain on Track - - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a [...]
G1 Therapeutics to Present at Investor Conferences in March 2018
01/03/2018
RESEARCH TRIANGLE PARK, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]
Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer
01/03/2018
SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track [...]
MPX Reports Q3 Fiscal 2018 Results
01/03/2018
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Corporation ” or “ MPX ”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its third quarter period ended December 31, 2017. (CDN$) 3 [...]

Pages